Target intelligence / Profile preview

Proline-rich transmembrane protein 1 (PRRT1)

Target
PRRT1
Molecular classification
Other (SynDIG protein family, Dispanin family), Membrane protein
01

Overview

Proline-rich transmembrane protein 1 (PRRT1) is a membrane protein primarily expressed in the brain, associated with the regulation of AMPA-type glutamate receptors (AMPARs) at extrasynaptic sites. PRRT1 is a component of native AMPAR complexes and is required for maintaining a pool of extrasynaptic AMPARs, thereby playing a critical role in synaptic plasticity such as long-term potentiation and depression. Knockout of PRRT1 in animal models leads to altered surface expression and phosphorylation of AMPARs, as well as impaired synaptic plasticity. PRRT1 is a member of the SynDIG protein family (specifically SynDIG4) and is also classified within the larger Dispanin protein family. It is involved in protein-protein interactions, especially with AMPAR subunits GluA1-GluA4 and the phosphatase PP2B, influencing the trafficking and stabilization of AMPARs during neuronal activity and memory processes[1][3][4][7]. No direct evidence currently implicates PRRT1 as a validated therapeutic target or indicates drug interactions, biomarker roles, or therapeutic safety concerns.

Other names
C6orf31NG5DSPD1SynDIG4IFITMD7Dispanin subfamily D member 1Synapse differentiation-induced protein 4interferon induced transmembrane protein domain containing 7
02

Biological functions

Regulation of AMPA receptor activityProtein localization to cell surfaceSynapse organizationLong-term synaptic potentiation and depressionLearning or memory
03

Disease associations

Neurodegenerative disease (Alzheimer disease)Sleep disorder (Delayed sleep phase disorder)Other (no evidence for major roles in cancer, inflammation, infection, or cardiovascular disease)

Beyond the preview

Go deeper on Proline-rich transmembrane protein 1 (PRRT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Proline-rich transmembrane protein 1 (PRRT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call